Proton Pump Inhibitors:
To use or not to use… That is the Question!

~ On demand beginning January 27, 2016 ~
(Recorded on January 26, 2016)

Please join NASPGHAN and the NASPGHAN Foundation for a 75-minute CME webinar on the latest scientific information regarding Proton Pump Inhibitors.

Release Date:    January 26, 2016
Expiration Date: January 26, 2019

Please review the following information, scroll down to the bottom of the page and click on the "REGISTER" link . After registering, the webinar player page link will be displayed. You will also receive an e-mail with this information.

Jenifer R Lightdale, MD, MPH
Professor of Pediatrics
University of Massachusetts Medical School
Worcester, MA
Carlo Di Lorenzo, MD
Professor of Pediatrics
The Ohio State University
Nationwide Children’s Hospital
Columbus, OH
Jose Garza, MD
Assistant Professor of Pediatrics
Children’s Ctr for Digestive Health Care, LLC
Atlanta, GA
Benjamin D. Gold, MD
Professor of Pediatrics and Microbiology
Children’s Ctr for Digestive Health Care. LLC
Atlanta, GA
Rachel Rosen, MD
Assistant Professor of Pediatrics
Harvard Medical School
Boston, MA

Henry Lin, MD
Assistant Professor of Pediatrics, University of Pennsylvania
Children's Hospital of Philadelphia, Philadelphia, PA

There is a need for ongoing education of both general pediatricians and pediatric gastroenterologists who care for pediatric patients with gastroesophageal reflux and its related disorders. There is increasing pressure to ensure appropriate management, including diagnostic and therapeutic strategies that minimize over- and under-utilization of testing and treatment. This program will arm the physician with essential education to ensure clarity surrounding current indications for use of proton pump inhibitors in children, as well as a growing understanding of risks associated with their use.

This activity is designed for pediatric and adult gastroenterologists who are interested in treating children and young adults with gastroesophageal reflux and its related disorders.

Upon completion of this activity, participants should be better able to:

• Differentiate Non-Erosive Reflux Disease (NERD) from Erosive Reflux Disease (ERD), Functional Heartburn and Hypersensitive Esophagus in regard to the physiological mechanisms for each of the above, as well as in diagnostic approach and treatment.

• Understand the pathophysiological basis for the most frequently described extra-esophageal associations with reflux disease, the biological plausibility for these associations, as well as when it might be appropriate to use a PPI for extra-esophageal conditions associated with reflux.

• Understand clear indications for when PPIs should be prescribed, as well as what to do when PPIs don’t work.

• Understand the risks of treatment, why, when and how to stop treatment, as well as what happens if you do not stop treatment.

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) and the NASPGHAN Foundation. NASPGHAN is accredited by the ACCME to provide continuing medical education for physicians.

NASPGHAN designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All faculty/speakers, planners, abstract reviewers, moderators, authors, coauthors, and administrative staff participating in the continuing medical education programs sponsored by NASPGHAN are expected to disclose to the program audience any/all relevant financial relationships related to the content of their presentation(s). Accordingly, the NASPGHAN staff have reported no financial relationships with any commercial interests related to the content of this educational activity.

Jenifer R Lightdale, MD is a consultant for Covidien, Perrigo and Mead Johnson.

Carlo Di Lorenzo, MD is a consultant for QOL, Inc. and Epstein Associates.

Jose Garza, MD has nothing to disclose.

Benjamin D. Gold, MD is Scientific/Medical Advisory Board Member for Johnson & Johnson, Pfizer, Nestle Nutrition USA; Consultant for Nutricia North America, Prometheus Laboratories and Horizon Pharma.

Rachel Rosen, MD has nothing to disclose.

Henry Lin, MD has nothing to disclose.

Paul Sinclair has nothing to disclose.

Amy Manela has nothing to disclose.

Rick Weimer has nothing to disclose.

In accordance with ACCME Standards for Commercial Support of CME, NASPGHAN and The NASPGHAN Foundation for Children’s Digestive Health and Nutrition implemented mechanisms to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.

To resolve identified conflicts of interest, the educational content was peer-reviewed by a physician member of the NASPGHAN Review Committee who has nothing to disclose. The resulting certified activity was found to provide educational content that is current, evidence-based, and commercially balanced.

This activity consists of a slide set plus online posttest and CME evaluation.

To receive CME credit for this activity, participants must review the CME information (learning objectives, disclosures, etc.), review the entire activity, and complete the activity posttest and evaluation questions.

To complete the activity posttest and evaluation, please visit THIS PAGE.

Certificates will be provided immediately after completion of both the posttest and evaluation. For any questions about receiving credit, please e-mail

Jointly sponsored by NASPGHAN and The NASPGHAN Foundation for Children’s Digestive Health and Nutrition.For questions, please contact:

714 Bethlehem Pike, Ambler, PA 19002
Phone: (215) 641-9800   Fax: (215) 641-1995

The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of NASPGHAN, The NASPGHAN Foundation for Children’s Digestive Health and Nutrition, or AstraZeneca. This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials on the subject matter before relying solely upon the information contained within this educational activity.

NASPGHAN and The NASPGHAN Foundation for Children’s Digestive Health and Nutrition will make every effort to protect the privacy of every individual participant of this activity and will use information gathered only to maintain records as required by the American Medical Association (AMA) and ACCME.

This activity does not require readers to register to review the material, with the exception of physicians and other health care providers who desire to receive CME credit for this accredited activity. If an individual completes a CME for this accredited activity, we are required by the AMA and ACCME to collect personal information on the individual, such as their name, address, and phone number, that will allow us to issue a CME certificate to them and to keep this information on file for up to 6 years. Personal information gathered will not be released to any other company or organization for any purpose. This information remains totally confidential.

PC or Mac, a high-speed Internet connection, speakers, and Flash 10 required. To update Flash, go here. You must also have a recent version of your Internet browser. You can check to make sure you're running the latest version here.

The webinar begins January 26, 2016 at 8:00pm ET. No content will be available prior to that time.

This educational activity is supported by an independent medical education grant from AstraZeneca.

© Copyright 2016 NASPGHAN and The NASPGHAN Foundation for Children’s Digestive Health and Nutrition.

Produced by Limelight Communications

I have read the information above and wish to REGISTER